# FDA Inspection 1020411 - Crestview Pharma, LLC - July 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/crestview-pharma-llc/88f33768-e432-4743-838e-7cd7551e0f0b
Source feed: FDA_Inspections

> FDA Inspection 1020411 for Crestview Pharma, LLC on July 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020411
- Company Name: Crestview Pharma, LLC
- Inspection Date: 2017-07-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/crestview-pharma-llc/f7893064-ca4a-48fc-b1a8-18011a3ec355

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d